US Patent Issued to ALCHEMEDICINE on Nov. 18 for "Heterocyclic compound as inhibitor of casein kinase 1-Delta and/or activin receptor-like kinase 5" (Japanese Inventor)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,274, issued on Nov. 18, was assigned to ALCHEMEDICINE INC. (Ibaraki, Japan).

"Heterocyclic compound as inhibitor of casein kinase 1-Delta and/or activin receptor-like kinase 5" was invented by Keigo Tanaka (Tsukuba, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An object of the present invention is to provide a compound having CK1Delta inhibition activity and/or ALK5 inhibition activity and the like. The object thereof can be attained by a compound represented by the following formula (1):wherein R1 to R10 each independently represent hydrogen, alkyl, cycloalkyl, or a halogen, wherein R2 and R3 or R4 and R5 together with two carbon atoms to w...